Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Gut Bacterium Sugar May Help Burn Visceral Fat and Combat Obesity

Gut Bacterium Sugar May Help Burn Visceral Fat and Combat Obesity

November 20, 2026 Health Desk Health

Sugar made by a gut bacterium can push visceral fat to burn more energy, and researchers in Singapore and the United States reported the finding on Thursday in Cell Host & Microbe.

Key Clinical Takeaways:

  • A gut bacterium, Clostridium immunis, produces a sugar that increases energy burning in visceral fat and reduces weight gain in preclinical work.
  • Across metagenomic data from 4,145 people worldwide, people with obesity carried fewer copies of the gene that modifies the sugar with phosphocholine.
  • The researchers have patented the discovery and plan clinical trials in the US.

The mechanism matters because visceral fat — the fat that wraps around internal organs — is closely linked to type 2 diabetes and cardiovascular disease, and it typically resists the signals that tell fat cells to burn energy. The phosphocholine-modified sugar acts, in the researchers’ words, like an “on switch” for weight gain reduction.

What the Cell Host & Microbe study found

Researchers from Duke-NUS Medical School and Duke University School of Medicine identified C. immunis, a bacterium that lives in the gut, and showed that it produces an exopolysaccharide — a sugar molecule — that requires a small chemical group called phosphocholine for its activity. When modified with that group, the sugar catalyzed reduced weight gain and reduced visceral fat accumulation.

The team then checked whether the pattern held in humans. Examining existing metagenomic data from 4,145 people globally, they found that people with obesity had fewer copies of the gene that adds phosphocholine than people with a body mass index below 25, the range international standards typically define as healthy.

Gut Bacterium Sugar May Help Burn Visceral Fat and Combat Obesity
Photo: miragenews.com

A different route to burning fat

What surprised the first author was not that the sugar worked, but how.

Dr Tan Chin Yee — who carried out the research while an MD-PhD student at Duke-NUS and in Duke University School of Medicine’s Department of Molecular Genetics and Microbiology, and who is currently part of the SingHealth Internal Medicine Residency Program — explained that the sugar altered the way visceral fat handled energy use rather than altering either what the body consumed or how active it was.

“What surprised us was that this bacterial sugar did not work by reducing food intake or increasing activity. Instead, it changed how visceral fat used energy. That gives us a completely different way of thinking about how gut bacteria can influence metabolism,” said Dr Tan Chin Yee, the study’s first author. Medicine's Department

Further investigation traced the pathway. The phosphocholine-modified sugar lowered levels of IL-22, a protein that helps the immune system communicate with tissues in the small intestine and visceral fat. That drop increased the number of fat cells carrying UCP1, a protein that lets cells release energy as heat. The more UCP1, the more energy burned — and the effect occurred specifically in visceral fat, the tissue usually resistant to such signals.

Why the timing matters

The finding lands against a widening public health backdrop. According to the figures cited in the study’s announcement, half the world’s population is expected to be overweight or obese by 2035, and in Singapore more than 12 per cent of the population is already living with obesity. The researchers have filed a patent on their discovery of C. immunis and the sugar it produces.

What the senior authors say

Senior author Assistant Professor Neeraj Surana, of the Department of Pediatrics at Duke University School of Medicine and the SingHealth Duke-NUS Paediatrics Academic Clinical Programme at SingHealth Duke-NUS Academic Medical Centre, presented the research as showing that gut bacteria talk to the body by way of sugars that have been chemically altered.

“Our findings reveal how some gut bacteria are able to uniquely communicate with the human body—they generate distinctive molecules by chemically modifying the sugars they produce. This opens up a new perspective on how the microbiome can influence human metabolism and points to new opportunities for developing treatments for metabolic diseases,” said Assistant Professor Neeraj Surana.

Professor Sheemei Lok, Interim Vice-Dean for Research at Duke-NUS, placed the study in the broader arc of microbiome research.

“This study moves us beyond simply knowing that the gut microbiome is associated with obesity. It identifies a specific molecule, a specific mechanism and a potential therapeutic pathway. That is the kind of translational insight needed if we are to turn microbiome science into new ways of preventing or treating metabolic diseases and tackling obesity.” said Professor Sheemei Lok.

Preclinical work links bacterium and sugar to metabolism; human trials not yet started

What the preclinical work establishes: a specific bacterium, a specific sugar, a defined immunometabolic mechanism, and a human correlation in metagenomic data from 4,145 people. What it does not yet establish: whether targeting C. immunis or its sugar safely reduces visceral fat in humans.

The researchers have filed a patent on the bacterium and the sugar, and they are planning clinical trials in the United States — the step that will test whether the mechanism translates. No trial start date, phase designation, or enrollment figures have been announced.

From bench to bedside

If clinical trials confirm the preclinical results, the discovery would point drug development toward molecules that raise energy expenditure in fat tissue directly — a route distinct from appetite suppression. The open question is whether a sugar made by a gut resident can do in people what it did in the lab. That answer waits on the US trials the team says it is planning.

Duke-NUS Medical School, where the study originated, was established in April 2005 as Singapore’s second medical school, a collaboration between Duke University in the United States and the National University of Singapore. It follows the American model of post-baccalaureate medical education, and its graduates receive degrees from both institutions.

The school sits within the Outram campus of Singapore General Hospital, where it moved in May 2009, and since SingHealth joined as its academic medicine partner it has formed part of the SingHealth Duke-NUS Academic Medical Centre.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Worth a look

  • UCSF Study: Wernicke’s Area Also Launches Speech Production
  • Smoking can triple the risk of pancreatic cancer

Related

bacteria, cell, food, genetics, Healthcare, Medical School, medicine, metabolism, microbiome, obesity, protein, research

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service